Chilton Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.1K | Hold |
2,000
| – | – | ﹤0.01% | 305 |
|
|
2025
Q1 | $80.4K | Hold |
2,000
| – | – | ﹤0.01% | 280 |
|
|
2024
Q4 | $94.1K | Hold |
2,000
| – | – | ﹤0.01% | 276 |
|
|
2024
Q3 | $106K | Hold |
2,000
| – | – | ﹤0.01% | 278 |
|
|
2024
Q2 | $108K | Hold |
2,000
| – | – | ﹤0.01% | 278 |
|
|
2024
Q1 | $140K | Sell |
2,000
-140
| -7% | -$9.82K | 0.01% | 264 |
|
|
2023
Q4 | $179K | Hold |
2,140
| – | – | 0.01% | 245 |
|
|
2023
Q3 | $63K | Hold |
2,140
| – | – | ﹤0.01% | 305 |
|
|
2023
Q2 | $69.8K | Sell |
2,140
-125
| -6% | -$4.08K | ﹤0.01% | 301 |
|
|
2023
Q1 | $79.7K | Buy |
+2,265
| New | +$79.7K | ﹤0.01% | 298 |
|
|
2022
Q3 | – | Sell |
-2,265
| Closed | -$89K | – | 300 |
|
|
2022
Q2 | $89K | Buy |
+2,265
| New | +$89K | 0.01% | 271 |
|
|
2022
Q1 | – | Sell |
-2,265
| Closed | -$103K | – | 303 |
|
|
2021
Q4 | $103K | Buy |
+2,265
| New | +$103K | 0.01% | 273 |
|